Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by GEORGE A CALIN and HUI LING.
GEORGE A CALIN
Connection Strength
4.103
HUI LING
  1. Non-coding RNAs: the cancer genome dark matter that matters! Clin Chem Lab Med. 2017 May 01; 55(5):705-714.
    View in: PubMed
    Score: 0.617
  2. MicroRNAs and other non-coding RNAs as targets for anticancer drug development. Nat Rev Drug Discov. 2013 Nov; 12(11):847-65.
    View in: PubMed
    Score: 0.484
  3. Principles of microRNA involvement in human cancers. Chin J Cancer. 2011 Nov; 30(11):739-48.
    View in: PubMed
    Score: 0.421
  4. Metformin blocks MYC protein synthesis in colorectal cancer via mTOR-4EBP-eIF4E and MNK1-eIF4G-eIF4E signaling. Mol Oncol. 2018 11; 12(11):1856-1870.
    View in: PubMed
    Score: 0.171
  5. OncomiR-10b hijacks the small molecule inhibitor linifanib in human cancers. Sci Rep. 2018 08 30; 8(1):13106.
    View in: PubMed
    Score: 0.169
  6. Cancer-associated rs6983267 SNP and its accompanying long noncoding RNA CCAT2 induce myeloid malignancies via unique SNP-specific RNA mutations. Genome Res. 2018 04; 28(4):432-447.
    View in: PubMed
    Score: 0.164
  7. To Wnt or Lose: The Missing Non-Coding Linc in Colorectal Cancer. Int J Mol Sci. 2017 Sep 20; 18(9).
    View in: PubMed
    Score: 0.158
  8. H19 Noncoding RNA, an Independent Prognostic Factor, Regulates Essential Rb-E2F and CDK8-?-Catenin Signaling in Colorectal Cancer. EBioMedicine. 2016 Nov; 13:113-124.
    View in: PubMed
    Score: 0.149
  9. Genome-Wide miRNA Analysis Identifies miR-188-3p as a Novel Prognostic Marker and Molecular Factor Involved in Colorectal Carcinogenesis. Clin Cancer Res. 2017 Mar 01; 23(5):1323-1333.
    View in: PubMed
    Score: 0.147
  10. MiR-223-5p works as an oncomiR in vulvar carcinoma by TP63 suppression. Oncotarget. 2016 08 02; 7(31):49217-49231.
    View in: PubMed
    Score: 0.146
  11. MicroRNA Processing and Human Cancer. J Clin Med. 2015 Aug 21; 4(8):1651-67.
    View in: PubMed
    Score: 0.137
  12. Design of a miRNA sponge for the miR-17 miRNA family as a therapeutic strategy against vulvar carcinoma. Mol Cell Probes. 2015 Dec; 29(6):420-426.
    View in: PubMed
    Score: 0.137
  13. The clinical and biological significance of MIR-224 expression in colorectal cancer metastasis. Gut. 2016 06; 65(6):977-989.
    View in: PubMed
    Score: 0.133
  14. CCAT2, a novel long non-coding RNA in breast cancer: expression study and clinical correlations. Oncotarget. 2013 Oct; 4(10):1748-62.
    View in: PubMed
    Score: 0.120
  15. HINCUTs in cancer: hypoxia-induced noncoding ultraconserved transcripts. Cell Death Differ. 2013 Dec; 20(12):1675-87.
    View in: PubMed
    Score: 0.120
  16. CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer. Genome Res. 2013 Sep; 23(9):1446-61.
    View in: PubMed
    Score: 0.118
  17. Non-coding RNAs for medical practice in oncology. Keio J Med. 2011; 60(4):106-13.
    View in: PubMed
    Score: 0.099
  18. The Long Noncoding RNA CCAT2 Induces Chromosomal Instability Through BOP1-AURKB Signaling. Gastroenterology. 2020 12; 159(6):2146-2162.e33.
    View in: PubMed
    Score: 0.048
  19. Therapeutic potential of FLANC, a novel primate-specific long non-coding RNA in colorectal cancer. Gut. 2020 10; 69(10):1818-1831.
    View in: PubMed
    Score: 0.047
  20. MiR-1287-5p inhibits triple negative breast cancer growth by interaction with phosphoinositide 3-kinase CB, thereby sensitizing cells for PI3Kinase inhibitors. Breast Cancer Res. 2019 02 01; 21(1):20.
    View in: PubMed
    Score: 0.044
  21. Publisher Correction: Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAs. Nat Commun. 2018 01 08; 9(1):160.
    View in: PubMed
    Score: 0.040
  22. Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAs. Nat Commun. 2017 11 27; 8(1):1801.
    View in: PubMed
    Score: 0.040
  23. N-BLR, a primate-specific non-coding transcript leads to colorectal cancer invasion and migration. Genome Biol. 2017 05 24; 18(1):98.
    View in: PubMed
    Score: 0.039
  24. miR-196b-5p Regulates Colorectal Cancer Cell Migration and Metastases through Interaction with HOXB7 and GALNT5. Clin Cancer Res. 2017 Sep 01; 23(17):5255-5266.
    View in: PubMed
    Score: 0.039
  25. MALAT1 promoted invasiveness of gastric adenocarcinoma. BMC Cancer. 2017 01 11; 17(1):46.
    View in: PubMed
    Score: 0.038
  26. Current Status of Long Non-Coding RNAs in Human Breast Cancer. Int J Mol Sci. 2016 Sep 06; 17(9).
    View in: PubMed
    Score: 0.037
  27. Therapeutic evaluation of microRNA-15a and microRNA-16 in ovarian cancer. Oncotarget. 2016 Mar 22; 7(12):15093-104.
    View in: PubMed
    Score: 0.036
  28. Allele-Specific Reprogramming of Cancer Metabolism by the Long Non-coding RNA CCAT2. Mol Cell. 2016 Feb 18; 61(4):640.
    View in: PubMed
    Score: 0.035
  29. Allele-Specific Reprogramming of Cancer Metabolism by the Long Non-coding RNA CCAT2. Mol Cell. 2016 Feb 18; 61(4):520-534.
    View in: PubMed
    Score: 0.035
  30. Long Noncoding RNA Ceruloplasmin Promotes Cancer Growth by Altering Glycolysis. Cell Rep. 2015 Dec 22; 13(11):2395-2402.
    View in: PubMed
    Score: 0.035
  31. Low spinophilin expression enhances aggressive biological behavior of breast cancer. Oncotarget. 2015 May 10; 6(13):11191-202.
    View in: PubMed
    Score: 0.034
  32. Spinophilin expression determines cellular growth, cancer stemness and 5-flourouracil resistance in colorectal cancer. Oncotarget. 2014 Sep 30; 5(18):8492-502.
    View in: PubMed
    Score: 0.032
  33. Regulation of pri-miRNA processing by a long noncoding RNA transcribed from an ultraconserved region. Mol Cell. 2014 Jul 03; 55(1):138-47.
    View in: PubMed
    Score: 0.032
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.